WWM
ABBV icon

Willingdon Wealth Management’s AbbVie ABBV Stock Holding History

Willingdon Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$4.8M Sell
63,067
-1,340
-2% -$114K 1.21% 29
2019
Q4 		$5.7M Buy
64,407
+60
+0.1% +$4.98K 1.17% 24
2019
Q3 		$4.87M Buy
64,347
+14,996
+30% +$1.03M 1.07% 27
2019
Q2 		$3.59M Sell
49,351
-454
-0.9% -$35.7K 0.83% 40
2019
Q1 		$4.01M Buy
49,805
+1,123
+2% +$91.9K 0.99% 31
2018
Q4 		$4.49M Sell
48,682
-1,632
-3% -$144K 1.29% 17
2018
Q3 		$4.76M Buy
50,314
+766
+2% +$72.6K 1.3% 19
2018
Q2 		$4.59M Buy
49,548
+135
+0.3% +$13.2K 1.4% 17
2018
Q1 		$4.68M Buy
49,413
+23,818
+93% +$2.62M 1.48% 15
2017
Q4 		$2.48M Sell
25,595
-43,435
-63% -$4.09M 0.81% 55
2017
Q3 		$6.13M Buy
69,030
+37,445
+119% +$2.85M 2.23% 4
2017
Q2 		$2.29M Buy
31,585
+1,674
+6% +$113K 0.91% 50
2017
Q1 		$1.95M Sell
29,911
-3,687
-11% -$232K 0.79% 57
2016
Q4 		$2.1M Sell
33,598
-3,350
-9% -$204K 0.99% 40
2016
Q3 		$2.33M Sell
36,948
-2,891
-7% -$187K 1.18% 25
2016
Q2 		$2.47M Buy
39,839
+2,096
+6% +$128K 1.27% 24
2016
Q1 		$2.16M Buy
37,743
+26,693
+242% +$1.49M 1.32% 26
2015
Q4 		$655K Buy
+11,050
New +$636K 0.6% 62
2015
Q2 		– Sell
-10,900
Closed -$638K – 85
2015
Q1 		$638K Buy
+10,900
New +$658K 0.53% 68

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Willingdon Wealth Management's ABBV Position: Q1 2020 in Review

Willingdon Wealth Management reduced its AbbVie (ABBV) stake by 2.1% in Q1 2020, selling an estimated $114K and leaving 63,067 shares worth $4.8M. The position accounts for 1.21% of the portfolio, ranked #29.

Willingdon Wealth Management first reported a position in ABBV in Q1 2015 and has held it in 19 quarters since. The position peaked at $6.13M in Q3 2017. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Willingdon Wealth Management held 63,067 shares of AbbVie worth $4.8M as of Q1 2020.
  • Willingdon Wealth Management sold 1,340 AbbVie shares in Q1 2020, an estimated $114K.
  • AbbVie made up 1.21% of Willingdon Wealth Management's portfolio in Q1 2020, its #29 holding.
  • Willingdon Wealth Management first reported a position in AbbVie in Q1 2015 and has held it in 19 quarters since.
  • Willingdon Wealth Management's AbbVie position peaked at $6.13M in Q3 2017.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.